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Background
Adenosine as a stress agent is well tolerated and has a
good safety profile but occasionally when administered
at 140mg/kg/min it fails to produce a haemodynamic or
symptomatic response.
Studies have reported that between 4 - 18% patients
do not respond to the standard dose1, 2.
Splenic switch-off is a novel way of assessing adequacy
of hyperaemic response, to adenosine3.
The aim of this study was to assess the number of
patients that required an increase in dose to either
175 mg/kg/min or 210 mg/kg/min over a 12-month per-
iod and the adequacy of this response using splenic
switch-off.
Methods
We retrospectively reviewed all patients who completed
an adenosine stress scan in the period from July 2013 to
July 2014. We identified those who had not responded
to the standard adenosine dose requiring an increased
dose. We recorded the physiological response to an
increased dose of adenosine, both haemodynamic and/
or symptomatic, and visually assessed the presence of
splenic-switch off.
Results
Over a year 955 patients had an adenosine stress scan.
74 patients (7.7%) did not respond to the standard dose
and the dose was increased to either 175 mg/kg/min or
210 mg/kg/min. 82% (61) of the 74 patients that under-
went an increased dose protocol had splenic switch off.
See table 1.
Of 11 patients who admitted to taking caffeine 10
(91%) had splenic switch off. 4 patients required the
adenosine stopping early because of transient heart
block, there were no other complications.
Conclusions
Similar to previous literature only a small percentage of
patients in our cohort needed an increased adenosine
dose. The majority (82%) subsequently demonstrated
splenic switch-off indicating an adequate hyperaemic
response. Our findings would support the use of
increasing adenosine infusion rates as being both safe
and effective. We now routinely increase infusion rates
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+ ve 61 (82.4%) 56 (75.7%) 5 (6.7%)
- ve 13 (17.6%) 10 (13.5%) 3 (4.1%)
Total 74 66 (89.2%) 8 (10.8%)
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